ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,783.00
-0.71%
S&P ASX All Technology
3,113.80
0.20%
Brent Oil
84.435
0.30%
US Dollar vs AUD
1.50348
-0.10%
Bitcoin
61,421.10
-0.63%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Knight Therapeutics Inc (GUD) Share Price

Knight Therapeutics Inc

Knight Therapeutics Inc (GUD)

GUD Holdings Limited
5.48
0.02
( 0.37% )
Updated: 02:28:13
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
5.48
Bid
5.46
Offer
5.49
Volume
10,662
5.45 Day's Range 5.52
4.35 52 Week Range 6.22
Market Cap
553.4M
Previous Close
5.46
Open
5.45
Last Trade
100
@
5.48
Last Trade Time
02:28:13
Financial Volume
-
VWAP
-
Average Volume (3m)
60,561
Shares Outstanding
101,170,000
Dividend Yield
-
PE Ratio
-32.87
Earnings Per Share (EPS)
-0.17
Revenue
331.1M
Net Profit
-16.84M

About Knight Therapeutics Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.gudknight.com
Headquarters
Montreal, Quebec, Can
Founded
1970
Knight Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker GUD. The last closing price for Knight Therapeutics was $5.46. Over the last year, Knight Therapeutics shares have traded in a share price range of $ 4.35 to $ 6.22.

Knight Therapeutics currently has 101,170,000 shares in issue. The market capitalisation of Knight Therapeutics is $553.40 million. Knight Therapeutics has a price to earnings ratio (PE ratio) of -32.87.

GUD Latest News

More News

Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an...

09 May 2024
GlobeNewswire Inc.

Knight Therapeutics Inc. announces voting results from the Annual General Meeting

MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Corporation") a leading pan-American (ex-US) specialty pharmaceutical company, announced today the...

09 May 2024
GlobeNewswire Inc.

Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City

MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:  GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia...

07 May 2024
GlobeNewswire Inc.

Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call

MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024...

02 May 2024
GlobeNewswire Inc.

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia...

09 April 2024
GlobeNewswire Inc.

Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity

MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on...

29 March 2024
GlobeNewswire Inc.

Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported...

21 March 2024
GlobeNewswire Inc.

Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call

MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and...

14 March 2024
GlobeNewswire Inc.

Trading For This Specialty Pharma Company is up Following Second Quarter Results

This stock is almost a penny stock no longer, as shares moved close to the $5 threshold following the firm’s quarterly announcement. Leading pan-American (ex-US) specialty pharmaceutical...

11 August 2023
AllPennyStocks.com
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10.020.36630036635.465.555.38480195.43276679CS
4-0.36-6.164383561645.846.055.38617855.75101526CS
120.244.580152671765.246.225.24605615.82505679CS
260.356.822612085775.136.225.13689945.59776303CS
520.7415.6118143464.746.224.35639195.23448753CS
1560.040.7352941176475.446.224.281502665.26598228CS
260-2.23-28.92347600527.718.884.282204675.94111977CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WELWinchester Energy Ltd
AUD 0.005
(150.00%)
3.87M
CNJConico Ltd
AUD 0.002
(100.00%)
4.97M
ICROInteliCare Holdings Limited
AUD 0.002
(100.00%)
911.35k
CLZClassic Minerals Limited
AUD 0.0015
(50.00%)
6.92M
SITSite Group International Ltd
AUD 0.003
(50.00%)
750k
LDROLode Resources Ltd
AUD 0.001
(-80.00%)
232.38k
DESODesoto Resources Ltd
AUD 0.01
(-54.55%)
5k
BASOBass Oil Limited
AUD 0.001
(-50.00%)
2.63M
BITOCBiotron Ltd
AUD 0.009
(-35.71%)
1.08M
IBGOIronbark Zinc Limited
AUD 0.002
(-33.33%)
833.33k
88E88 Energy Limited
AUD 0.002
(0.00%)
206.71M
SYASayona Mining Limited
AUD 0.035
(1.45%)
78.13M
LTRLiontown Resources Limited
AUD 0.94
(4.16%)
54.89M
COECooper Energy Limited
AUD 0.22
(-4.35%)
44.87M
PLSPilbara Minerals Limited
AUD 3.24
(2.69%)
43.54M

GUD Discussion

View Posts
sumotrader sumotrader 8 years ago
Loaded 1600 more shares today. GUD is about to take off.
👍️0
CommonCents4Dollars CommonCents4Dollars 9 years ago
This must be some sort of record,.. " the Company reported revenues of $109,608 and net income of $124,981,439."

http://www.gud-knight.com/en/knight-reports-fourth-quarter-and-year-ended-december-31-2014-results
👍️0
CommonCents4Dollars CommonCents4Dollars 9 years ago
Knight Therapeutics GUD.TO : Mackie Research starts with buy rating; target price of C$12

http://www.investorvillage.com/groups.asp?mb=6781&mn=83648&pt=msg&mid=14732670
👍️0
OneStepAhead OneStepAhead 9 years ago
On a tear
👍️0
CommonCents4Dollars CommonCents4Dollars 9 years ago
GOD is GUD. :)
👍️0
CommonCents4Dollars CommonCents4Dollars 9 years ago
KHTRF is the OTC Ticker for Americans
or
GUD on the TSX for Canadians


LONG on this one.
👍️0
CommonCents4Dollars CommonCents4Dollars 9 years ago
GUD is flying along nicely,.. Paladin II is in GUD hands, Goodman building another BEAST!
👍️0
OneStepAhead OneStepAhead 9 years ago
GUD Knight Therapeutics

Knight Therapeutics Inc. ("Knight" or the "Company") (TSX:GUD) today announced that it has entered into a bought deal agreement with a syndicate of underwriters led by GMP Securities L.P. and including Cormark Securities Inc., National Bank Financial Inc., Laurentian Bank Securities Inc., Bloom Burton & Co., Clarus Securities Inc., Mackie Research Capital Corporation and TD Securities Inc. (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase 11,111,120 common shares of the Company (the "Common Shares") at a price of $6.75 per Common Share for gross proceeds to Knight of $75,000,060 (the "Offering"). In addition, the Underwriters will have the option, exercisable for a period of 30 days after the closing date, to acquire up to an aggregate of 1,666,668 additional Common Shares ($11,250,009) at the offering price to cover over-allotments, if any (the "Over-Allotment Option"). If the Over-Allotment Option is exercised in full, the total gross proceeds of the Offering shall be $86,250,069.

http://www.marketwired.com/press-release/knight-therapeutics-enters-into-agreement-75-million-bought-deal-common-shares-tsx-gud-1973898.htm
👍️0
OneStepAhead OneStepAhead 9 years ago
GUD Knight Therapeutics

After selling off his specialty pharmaceutical company Paladin Labs Inc. in a deal worth $3-billion, Montreal entrepreneur Jonathan Goodman is starting from scratch with a new drug distribution venture.

http://www.theglobeandmail.com/globe-investor/investment-ideas/a-fresh-stock-with-a-veteran-face/article17189152/
👍️0
Greedy G Greedy G 10 years ago
TNEN:

http://stockcharts.com/h-sc/ui?s=TNEN&p=D&b=5&g=0&id=p74917584188
👍️0

Your Recent History

TSX
GUD
Knight Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved